DrugPatentWatch Database Preview
Sanofi Us Services Company Profile
Email this page to a colleague
» See Plans and PricingUS Patents for Sanofi Us Services
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Us Services | TOUJEO MAX SOLOSTAR | insulin glargine recombinant | SOLUTION;SUBCUTANEOUS | 206538 | 002 | 2015-09-29 | 9,474,688 | Corning Incorporated (Corning, NY) | 2031-10-25 | RX | search | |
| Sanofi Us Services | TOUJEO MAX SOLOSTAR | insulin glargine recombinant | SOLUTION;SUBCUTANEOUS | 206538 | 002 | 2015-09-29 | 8,399,006 | Forsight Vision4, Inc. (Menlo Park, CA) | 2029-01-29 | RX | search | |
| Sanofi Us Services | TOUJEO MAX SOLOSTAR | insulin glargine recombinant | SOLUTION;SUBCUTANEOUS | 206538 | 002 | 2015-09-29 | 8,277,830 | ForSight Vision4, Inc. (Menlo Park, CA) | 2029-01-29 | RX | search | |
| Sanofi Us Services | TOUJEO SOLOSTAR | insulin glargine recombinant | SOLUTION;SUBCUTANEOUS | 206538 | 001 | 2015-09-29 | 9,474,688 | Corning Incorporated (Corning, NY) | 2031-10-25 | RX | search | |
| Sanofi Us Services | TOUJEO SOLOSTAR | insulin glargine recombinant | SOLUTION;SUBCUTANEOUS | 206538 | 001 | 2015-09-29 | 8,399,006 | Forsight Vision4, Inc. (Menlo Park, CA) | 2029-01-29 | RX | search | |
| Sanofi Us Services | TOUJEO SOLOSTAR | insulin glargine recombinant | SOLUTION;SUBCUTANEOUS | 206538 | 001 | 2015-09-29 | 8,277,830 | ForSight Vision4, Inc. (Menlo Park, CA) | 2029-01-29 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Similar Applicant Names
Companies are sometimes listed under multiple names.
This search can help find similar names.
This search can help find similar names.
